Literature DB >> 12494448

Cyclin T: three forms for different roles in physiological and pathological functions.

Antonio De Luca1, Maria De Falco, Alfonso Baldi, Marco G Paggi.   

Abstract

Cyclins are members of family of proteins involved in the cell cycle regulation. They are regulatory subunits of complexes with proteins called cyclin-dependent kinases (CDKs). There are three forms of cyclin T: cyclin T1, cyclin T2a, and T2b. All cyclin T contain an N-terminal "cyclin homology box," the most conserved region among different members of the cyclin family that serves to bind CDK9. In addition to the N-terminal cyclin domain, cyclin T contains a putative coiled-coil motif, a His-rich motif, and a C-terminal PEST sequence. The CDK9/cyclin T complex is able to activate gene expression in a catalytic-dependent manner, phosphorylating the carboxy-terminal domain (CTD) of RNA polymerase II. In addition, only cyclin T1 supports interactions between Tat and TAR. The interaction of Tat with cyclin T1 alters the conformation of Tat to enhance the affinity and specificity of the Tat:TAR interaction. On the other hand, CDK9/cyclin T2 complexes are involved in the regulation of terminal differentiation in muscle cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12494448     DOI: 10.1002/jcp.10196

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  25 in total

1.  Transcriptional regulation of HIV-1 gene expression by p53.

Authors:  Ruma Mukerjee; Pier Paolo Claudio; J Robert Chang; Luis Del Valle; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

2.  A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

Authors:  Dorothee Mueller; Christian Bach; Deniz Zeisig; Maria-Paz Garcia-Cuellar; Sara Monroe; Arun Sreekumar; Rong Zhou; Alexey Nesvizhskii; Arul Chinnaiyan; Jay L Hess; Robert K Slany
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

3.  Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7.

Authors:  Sama Tamrakar; Anokhi J Kapasi; Deborah H Spector
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 4.  A role for CDK9-cyclin K in maintaining genome integrity.

Authors:  David S Yu; David Cortez
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

5.  Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma.

Authors:  Jong-Shiaw Jin; Lien-Fu Lin; Jui-Chang Chen; Chia-Chi Huang; Jeng-Horng Sheu; Wenlung Chen; Tang-Yi Tsao; Chih-Wei Hsu
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

6.  Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.

Authors:  Jikai Yin; Charles Lu; Jian Gu; Scott M Lippman; Michelle A T Hildebrandt; Jie Lin; David Stewart; Margaret R Spitz; Xifeng Wu
Journal:  Carcinogenesis       Date:  2011-09-28       Impact factor: 4.944

7.  Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9.

Authors:  Kyuwon Baek; Raymond S Brown; Gabriel Birrane; John A A Ladias
Journal:  J Mol Biol       Date:  2006-11-18       Impact factor: 5.469

8.  Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.

Authors:  S-W Grace Cheng; Michael A Kuzyk; Annie Moradian; Taka-Aki Ichu; Vicky C-D Chang; Jerry F Tien; Sarah E Vollett; Malachi Griffith; Marco A Marra; Gregg B Morin
Journal:  Mol Cell Biol       Date:  2012-09-17       Impact factor: 4.272

9.  Positive cyclin T expression as a favorable prognostic factor in treating gastric gastrointestinal stromal tumors.

Authors:  Lien-Fu Lin; Jong-Shiaw Jin; Jui-Chang Chen; Chia-Chi Huang; Jeng-Horng Sheu; Wenlung Chen; Tang-Yi Tsao; Chih-Wei Hsu
Journal:  Mol Clin Oncol       Date:  2016-03-30

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.